Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522236
Status:
COMPLETED
Last Update Posted:
2012-01-25
First Post:
2007-08-28
Brief Title:
Safety and Immunogenicity of a Commercially Available Influenza Vaccine Formulation 20072008 When Administered to Elderly Subjects
Sponsor:
Novartis Vaccines
Organization:
Novartis
Study Overview
Official Title:
A Phase II Open Label Uncontrolled Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen Inactivated Adjuvanted Influenza Vaccine Formulation 2007-2008 When Administered to Elderly Subjects
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the antibody response to each influenza vaccine antigen when administering a single dose to subjects aged 65 years and over
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007-000966-19 | None | None | None |